These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 9678415)

  • 1. Ocular hypotensive and vasodilative effects of two beta-adrenergic blockers with intrinsic sympathomimetic activity.
    Hong SJ; Wu KY; Chen IJ
    Curr Eye Res; 1998 Jul; 17(7):700-7. PubMed ID: 9678415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaninolol: a novel compound for the treatment of glaucoma and ischemic retinopathy.
    Wu BN; Hong SJ; Sheu MM; Chen IJ; Liu SX; Chiou GC
    J Ocul Pharmacol Ther; 1995; 11(3):213-20. PubMed ID: 8590252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8OH-DPAT-Induced ocular hypotension: sites and mechanisms of action.
    Chu TC; Ogidigben MJ; Potter DE
    Exp Eye Res; 1999 Aug; 69(2):227-38. PubMed ID: 10433858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological effects of topical timolol in the rabbit eye.
    Bartels SP; Roth HO; Jumblatt MM; Neufeld AH
    Invest Ophthalmol Vis Sci; 1980 Oct; 19(10):1189-97. PubMed ID: 6106643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of ocular blood flow with dopamine antagonists on ocular-hypertensive rabbit eyes.
    Chiou GC; Chen YJ
    Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):481-4. PubMed ID: 1302433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of adrenomedullin on cyclic AMP formation and on relaxation in iris sphincter smooth muscle.
    Yousufzai SY; Ali N; Abdel-Latif AA
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3245-53. PubMed ID: 10586949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilatory mechanism of levobunolol on vascular smooth muscle cells.
    Dong Y; Ishikawa H; Wu Y; Yoshitomi T
    Exp Eye Res; 2007 Jun; 84(6):1039-46. PubMed ID: 17459374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine.
    Ogidigben M; Chu TC; Potter DE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):822-7. PubMed ID: 7902435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topical beta-blockers on the diameter of the isolated porcine short posterior ciliary artery.
    Braakman R; van der Linden P; Sipkema P
    Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):370-7. PubMed ID: 9950595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit.
    Vareilles P; Silverstone D; Plazonnet B; Le Douarec JC; Sears ML; Stone CA
    Invest Ophthalmol Vis Sci; 1977 Nov; 16(11):987-96. PubMed ID: 21145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular effects of adrenomedullin.
    Taniguchi T; Kawase K; Gu ZB; Kimura M; Okano Y; Kawakami H; Tsuji A; Kitazawa Y
    Exp Eye Res; 1999 Nov; 69(5):467-74. PubMed ID: 10548466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanidilol: a vanilloid-type vasorelaxant and ocular hypotensive beta-adrenoceptor blocker with partial beta-2-agonist activity.
    Sheu MM; Wu BN; Ho WC; Hong SJ; Chen SJ; Lin YT; Chen IJ
    Pharmacology; 1997 Apr; 54(4):211-24. PubMed ID: 9211567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-653,328: an ocular hypotensive agent with modest beta receptor blocking activity.
    Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Baldwin JJ; Ponticello GS; Varga SL
    Invest Ophthalmol Vis Sci; 1988 May; 29(5):776-84. PubMed ID: 2896641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic and adrenergic modulation of the Ca2+ response to endothelin-1 in human ciliary muscle cells.
    Prasanna G; Dibas AI; Yorio T
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1142-8. PubMed ID: 10752952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of C-nitropyrazoles and C-nitroazoles on ocular blood flow and retinal function recovery after ischemic insult.
    Xuan B; Wang T; Chiou GC; Dalinger IL; Shkineva TK; Shevelev SA
    Acta Pharmacol Sin; 2002 Aug; 23(8):705-12. PubMed ID: 12147192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular hypotension in the rabbit. Receptor mechanisms of pirbuterol and nylidrin.
    Mittag TW; Tormay A; Messenger M; Podos SM
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):163-9. PubMed ID: 2857689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular hypotensive action of topical flunarizine in the rabbit: role of sigma 1 recognition sites.
    Campana G; Bucolo C; Murari G; Spampinato S
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1086-94. PubMed ID: 12438531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ocular penetration of topical forskolin and its effects on intraocular pressure, aqueous flow rate and cyclic AMP level in the rabbit eye.
    Matsumoto S; Yamashita T; Araie M; Kametani S; Hosokawa T; Takase M
    Jpn J Ophthalmol; 1990; 34(4):428-35. PubMed ID: 1964483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug effects on intraocular pressure and vascular flow in the bovine perfused eye using radiolabelled microspheres.
    Millar JC; Wilson WS; Carr RD; Humphries RG
    J Ocul Pharmacol Ther; 1995; 11(1):11-23. PubMed ID: 8535953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes.
    Sharif NA; Xu SX; Crider JY; McLaughlin M; Davis TL
    J Ocul Pharmacol Ther; 2001 Aug; 17(4):305-17. PubMed ID: 11572462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.